Greipp PR - Search Results

1

Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.

Timm MM, Kimlinger TK, Haug JL, Kline MP, Greipp PR, Rajkumar SV, Kumar SK. Timm MM, et al. Among authors: greipp pr. Leukemia. 2006 Oct;20(10):1863-9. doi: 10.1038/sj.leu.2404359. Epub 2006 Aug 17. Leukemia. 2006. PMID: 16932343

2

A phase II trial of imatinib in patients with refractory/relapsed myeloma.

Dispenzieri A, Gertz MA, Lacy MQ, Geyer SM, Greipp PR, Rajkumar SV, Kimlinger T, Lust JA, Fonseca R, Allred J, Witzig TE. Dispenzieri A, et al. Among authors: greipp pr. Leuk Lymphoma. 2006 Jan;47(1):39-42. doi: 10.1080/10428190500271269. Leuk Lymphoma. 2006. PMID: 16321825 Clinical Trial.

3

Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?

Mongkonsritragoon W, Kimlinger T, Ahmann G, Greipp PR. Mongkonsritragoon W, et al. Among authors: greipp pr. Leuk Lymphoma. 1998 May;29(5-6):577-84. doi: 10.3109/10428199809050917. Leuk Lymphoma. 1998. PMID: 9643571

4

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: greipp pr. Leukemia. 1999 Mar;13(3):469-72. doi: 10.1038/sj.leu.2401336. Leukemia. 1999. PMID: 10086738

5

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.

Fonseca R, Hoyer JD, Aguayo P, Jalal SM, Ahmann GJ, Rajkumar SV, Witzig TE, Lacy MQ, Dispenzieri A, Gertz MA, Kyle RA, Greipp PR. Fonseca R, et al. Among authors: greipp pr. Leuk Lymphoma. 1999 Nov;35(5-6):599-605. doi: 10.1080/10428199909169625. Leuk Lymphoma. 1999. PMID: 10609798

6

Prognostic factors in multiple myeloma.

Rajkumar SV, Greipp PR. Rajkumar SV, et al. Among authors: greipp pr. Hematol Oncol Clin North Am. 1999 Dec;13(6):1295-314, xi. doi: 10.1016/s0889-8588(05)70128-3. Hematol Oncol Clin North Am. 1999. PMID: 10626152 Review.

7

Angiogenesis in multiple myeloma.

Rajkumar SV, Greipp PR. Rajkumar SV, et al. Among authors: greipp pr. Br J Haematol. 2001 Jun;113(3):565. doi: 10.1046/j.1365-2141.2001.02690.x. Br J Haematol. 2001. PMID: 11380438 Free article. No abstract available.

8

Thalidomide for previously untreated indolent or smoldering multiple myeloma.

Rajkumar SV, Dispenzieri A, Fonseca R, Lacy MQ, Geyer S, Lust JA, Kyle RA, Greipp PR, Gertz MA, Witzig TE. Rajkumar SV, et al. Among authors: greipp pr. Leukemia. 2001 Aug;15(8):1274-6. doi: 10.1038/sj.leu.2402183. Leukemia. 2001. PMID: 11480571 Clinical Trial.

9

Thalidomide as initial therapy for early-stage myeloma.

Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A, Fonseca R, Geyer SM, Iturria N, Kumar S, Lust JA, Kyle RA, Greipp PR, Witzig TE. Rajkumar SV, et al. Among authors: greipp pr. Leukemia. 2003 Apr;17(4):775-9. doi: 10.1038/sj.leu.2402866. Leukemia. 2003. PMID: 12682636 Clinical Trial.

10

Expression of VEGF and its receptors by myeloma cells.

Kumar S, Witzig TE, Timm M, Haug J, Wellik L, Fonseca R, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: greipp pr. Leukemia. 2003 Oct;17(10):2025-31. doi: 10.1038/sj.leu.2403084. Leukemia. 2003. PMID: 14513053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters